Publications

2022


  1. Vuorinen, S, Syrjänen, K, Waterboer, T, Grénman, S, Syrjänen, S, Louvanto, K et al.. Outcomes of HPV type-specific serostatus do not associate with oral or genital HPV-carriage in non-vaccinated women followed for three years. BMC Womens Health. 2022;22 (1):141. doi: 10.1186/s12905-022-01717-x. PubMed PMID:35484584 PubMed Central PMC9052499.
  2. Lehtinen, M, Gray, P, Louvanto, K, Vänskä, S. In 30 years, gender-neutral vaccination eradicates oncogenic human papillomavirus (HPV) types while screening eliminates HPV-associated cancers. Expert Rev Vaccines. 2022;21 (6):735-738. doi: 10.1080/14760584.2022.2064279. PubMed PMID:35404177 .
  3. Louvanto, K, Baral, P, Burchell, A, Ramanakumar, A, El-Zein, M, Tellier, PP et al.. Role of Human Leukocyte Antigen Allele Sharing in Human Papillomavirus Infection Transmission Among Heterosexual Couples: Findings From the Hitch Cohort Study. J Infect Dis. 2022; :. doi: 10.1093/infdis/jiac115. PubMed PMID:35363864 .
  4. Syrjänen, S, Waterboer, T, Rintala, M, Pawlita, M, Syrjänen, K, Louvanto, K et al.. Maternal HPV-antibodies and seroconversion to HPV in children during the first 3 years of life. Sci Rep. 2022;12 (1):2227. doi: 10.1038/s41598-022-06343-z. PubMed PMID:35140326 PubMed Central PMC8828864.
  5. Suominen, NT, Jaakola, AJ, Roger, M, Faucher, MC, Syrjänen, KJ, Grénman, SE et al.. The association of HLA-G polymorphism with oral and genital HPV infection in men. Eur J Clin Microbiol Infect Dis. 2022;41 (2):219-226. doi: 10.1007/s10096-021-04362-8. PubMed PMID:34697671 PubMed Central PMC8770419.

Search PubMed

2021


  1. Suominen, NT, Jaakola, AJ, Roger, M, Faucher, MC, Syrjänen, KJ, Grénman, SE et al.. The association of HLA-G polymorphism with oral and genital HPV infection in men. Eur J Clin Microbiol Infect Dis. 2022;41 (2):219-226. doi: 10.1007/s10096-021-04362-8. PubMed PMID:34697671 PubMed Central PMC8770419.
  2. Jaakola, A, Roger, M, Faucher, MC, Syrjänen, K, Grénman, S, Syrjänen, S et al.. HLA-G polymorphism impacts the outcome of oral HPV infections in women. BMC Infect Dis. 2021;21 (1):419. doi: 10.1186/s12879-021-06079-7. PubMed PMID:33947339 PubMed Central PMC8097798.
  3. Bergqvist, L, Kalliala, I, Aro, K, Auvinen, E, Jakobsson, M, Kiviharju, M et al.. Distribution of HPV Genotypes Differs Depending on Behavioural Factors among Young Women. Microorganisms. 2021;9 (4):. doi: 10.3390/microorganisms9040750. PubMed PMID:33918429 PubMed Central PMC8066411.
  4. Syrjänen, S, Rintala, M, Sarkola, M, Willberg, J, Rautava, J, Koskimaa, H et al.. Oral Human Papillomavirus Infection in Children during the First 6 Years of Life, Finland. Emerg Infect Dis. 2021;27 (3):759-766. doi: 10.3201/eid2703.202721. PubMed PMID:33513331 PubMed Central PMC7920652.
  5. Robles, C, Bruni, L, Acera, A, Riera, JC, Prats, L, Poljak, M et al.. Determinants of Human Papillomavirus Vaccine Uptake by Adult Women Attending Cervical Cancer Screening in 9 European Countries. Am J Prev Med. 2021;60 (4):478-487. doi: 10.1016/j.amepre.2020.08.032. PubMed PMID:33358719 .

Search PubMed

2020


  1. Robles, C, Bruni, L, Acera, A, Riera, JC, Prats, L, Poljak, M et al.. Determinants of Human Papillomavirus Vaccine Uptake by Adult Women Attending Cervical Cancer Screening in 9 European Countries. Am J Prev Med. 2021;60 (4):478-487. doi: 10.1016/j.amepre.2020.08.032. PubMed PMID:33358719 .
  2. Louvanto, K, Eriksson, T, Gray, P, Apter, D, Baussano, I, Bly, A et al.. Baseline findings and safety of infrequent vs. frequent screening of human papillomavirus vaccinated women. Int J Cancer. 2020;147 (2):440-447. doi: 10.1002/ijc.32802. PubMed PMID:31749143 .
  3. Louvanto, K, Aro, K, Nedjai, B, Bützow, R, Jakobsson, M, Kalliala, I et al.. Methylation in Predicting Progression of Untreated High-grade Cervical Intraepithelial Neoplasia. Clin Infect Dis. 2020;70 (12):2582-2590. doi: 10.1093/cid/ciz677. PubMed PMID:31344234 PubMed Central PMC7286376.

Search PubMed

2019


  1. Louvanto, K, Eriksson, T, Gray, P, Apter, D, Baussano, I, Bly, A et al.. Baseline findings and safety of infrequent vs. frequent screening of human papillomavirus vaccinated women. Int J Cancer. 2020;147 (2):440-447. doi: 10.1002/ijc.32802. PubMed PMID:31749143 .
  2. Malagón, T, Louvanto, K, Ramanakumar, AV, Koushik, A, Coutlée, F, Franco, EL et al.. Viral load of human papillomavirus types 16/18/31/33/45 as a predictor of cervical intraepithelial neoplasia and cancer by age. Gynecol Oncol. 2019;155 (2):245-253. doi: 10.1016/j.ygyno.2019.09.010. PubMed PMID:31604665 .
  3. Aro, K, Nieminen, P, Louvanto, K, Jakobsson, M, Virtanen, S, Lehtinen, M et al.. Age-specific HPV type distribution in high-grade cervical disease in screened and unvaccinated women. Gynecol Oncol. 2019;154 (2):354-359. doi: 10.1016/j.ygyno.2019.05.024. PubMed PMID:31176553 .
  4. Wissing, MD, Louvanto, K, Comète, E, Burchell, AN, El-Zein, M, Rodrigues, A et al.. Human Papillomavirus Viral Load and Transmission in Young, Recently Formed Heterosexual Couples. J Infect Dis. 2019;220 (7):1152-1161. doi: 10.1093/infdis/jiz238. PubMed PMID:31063542 PubMed Central PMC6736425.
  5. El-Zein, M, Bouten, S, Louvanto, K, Gilbert, L, Gotlieb, WH, Hemmings, R et al.. Predictive Value of HPV Testing in Self-collected and Clinician-Collected Samples Compared with Cytology in Detecting High-grade Cervical Lesions. Cancer Epidemiol Biomarkers Prev. 2019;28 (7):1134-1140. doi: 10.1158/1055-9965.EPI-18-1338. PubMed PMID:31015201 .
  6. Paaso, A, Jaakola, A, Syrjänen, S, Louvanto, K. From HPV Infection to Lesion Progression: The Role of HLA Alleles and Host Immunity. Acta Cytol. 2019;63 (2):148-158. doi: 10.1159/000494985. PubMed PMID:30783048 .
  7. Malagón, T, Louvanto, K, Wissing, M, Burchell, AN, Tellier, PP, El-Zein, M et al.. Hand-to-genital and genital-to-genital transmission of human papillomaviruses between male and female sexual partners (HITCH): a prospective cohort study. Lancet Infect Dis. 2019;19 (3):317-326. doi: 10.1016/S1473-3099(18)30655-8. PubMed PMID:30745276 PubMed Central PMC6404546.

Search PubMed

2018


  1. El-Zein, M, Bouten, S, Louvanto, K, Gilbert, L, Gotlieb, W, Hemmings, R et al.. Validation of a new HPV self-sampling device for cervical cancer screening: The Cervical and Self-Sample In Screening (CASSIS) study. Gynecol Oncol. 2018;149 (3):491-497. doi: 10.1016/j.ygyno.2018.04.004. PubMed PMID:29678360 .
  2. Louvanto, K, Roger, M, Faucher, MC, Syrjänen, K, Grenman, S, Syrjänen, S et al.. HLA-G and vertical mother-to-child transmission of human papillomavirus infection. Hum Immunol. 2018;79 (6):471-476. doi: 10.1016/j.humimm.2018.03.002. PubMed PMID:29544814 .
  3. Tainio, K, Athanasiou, A, Tikkinen, KAO, Aaltonen, R, Cárdenas, J, Hernándes, et al.. Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis. BMJ. 2018;360 :k499. doi: 10.1136/bmj.k499. PubMed PMID:29487049 PubMed Central PMC5826010.
  4. Faucher, MC, Louvanto, K, Syrjänen, S, Roger, M. Characterisation of the novel HLA-G null allele, HLA-G*01:21N, in Finnish individuals. HLA. 2018;91 (2):146-147. doi: 10.1111/tan.13177. PubMed PMID:29152919 .

Search PubMed